Life Diagnostics, Inc. adds three new thymidine kinase 1 (TK1) assays to its lineup of over 85 SPARCL assays. The assays were developed for cats (TK1-SP-8), dogs (TK1-SP-4), and humans (TK1-SP-20).
Thymidine kinase 1 (TK1) is an enzyme involved in DNA synthesis. Its expression levels increase in tissues such as tumors that are proliferating. Upon tumor cell death and lysis, TK1 is released into
serum.
- In cats, TK1 is a potential biomarker for lymphoma.
- In dogs, it provides a biomarker for lymphoma and mammary tumors.
- In humans, TK1 provides a biomarker for tumor growth and metastasis.
In addition to fully developed and tested SPARCL assay kits, Life Diagnostics provides HRP and acridan conjugation services for the development of new SPARCL assays. Please visit the Life Diagnostics SPARCL Assay web page for more information.
